博安生物(06955)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

06955 博安生物

未开盘 08-13 16:08:27

17.290

+0.010

+0.06%

最高17.620	最低16.810	成交量1,776万
今开17.370	昨收17.280	日振幅4.69%
总市值99.24亿	流通市值99.24亿	总股本5.74亿
成交额3.05亿	换手率3.09%	流通股本5.74亿
市净率5.52	ROE4.94%	每股收益0.15
52周最高25.000	52周最低7.510	市盈率115.82
股息0.00	股息收益率0.00	ROA1.48%

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"06955","market":"HK","secType":"STK","nameCN":"博安生物","latestPrice":17.29,"timestamp":1755072507006,"preClose":17.28,"halted":0,"volume":17764400,"delay":0,"floatShares":574000000,"shares":574000000,"eps":0.1492771794127112,"marketStatus":"未开盘","change":0.01,"latestTime":"08-13 16:08:27","open":17.37,"high":17.62,"low":16.81,"amount":305295507,"amplitude":0.046875,"askPrice":17.29,"askSize":35400,"bidPrice":17.24,"bidSize":22800,"shortable":3,"etf":0,"ttmEps":0.1492771794127112,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1755135000000},"marketStatusCode":0,"adr":0,"listingDate":1672329600000,"exchange":"SEHK","adjPreClose":17.28,"openAndCloseTimeList":[[1755048600000,1755057600000],[1755061200000,1755072000000]],"volumeRatio":0.7981382752167295,"lotSize":200,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/06955","defaultTab":"news","newsList":[{"id":"2558819690","title":"博安生物盘中异动 早盘股价大跌5.02%报17.600港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2558819690","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2558819690?lang=zh_cn&edition=full","pubTime":"2025-08-12 10:52","pubTimestamp":1754967128,"startTime":"0","endTime":"0","summary":"2025年08月12日早盘10时52分，博安生物股票出现异动，股价快速跳水5.02%。截至发稿，该股报17.600港元/股，成交量770.52万股，换手率1.34%，振幅5.29%。资金方面，该股资金流入3859.43万港元，流出6435.28万港元。最近的财报数据显示，该股实现营业收入7.84亿港元，净利润7,903.44万港元，每股收益0.15港元，毛利5.86亿港元，市盈率127.90倍。博安生物股票所在的生物技术行业中，整体跌幅为1.73%。该信息摘要如下：17、8月5日，FDA官网显示，信达生物的IBI3032获批临床。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025081210521194dde90a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025081210521194dde90a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["06955","BK1161"],"gpt_icon":0},{"id":"2558554366","title":"每日卖空追踪 | 博安生物 08月11日卖空量成交31万股，卖空比例为1.33%","url":"https://stock-news.laohu8.com/highlight/detail?id=2558554366","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2558554366?lang=zh_cn&edition=full","pubTime":"2025-08-11 16:30","pubTimestamp":1754901037,"startTime":"0","endTime":"0","summary":"博安生物北京时间08月11日，涨0.71%，卖空量成交31万股%，较上一交易日减少58.95%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250811172012a481af22&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250811172012a481af22&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["06955","BK1161"],"gpt_icon":0},{"id":"2558635034","title":"港股异动 | 博安生物(06955)涨超3% 度拉糖肽注射液博优平®在中国获批上市 商业化与上药控股合作开展","url":"https://stock-news.laohu8.com/highlight/detail?id=2558635034","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2558635034?lang=zh_cn&edition=full","pubTime":"2025-08-11 12:00","pubTimestamp":1754884845,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，博安生物涨超3%，截至发稿，涨2.61%，报18.88港元，成交额3.13亿港元。消息面上，8月8日，博安生物发布公告，公司自主开发的博优平已获得国家药品监督管理局的上市批准，用于成人2型糖尿病患者的血糖控制。博优平在中国内地的商业化由公司与上药控股有限公司合作开展。在中国市场之外，博优平也已在美国获准开展临床试验。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1327882.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"港股异动 | 博安生物(06955)涨超3% 度拉糖肽注射液博优平®在中国获批上市 商业化与上药控股合作开展","news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["06955","BK1161"],"gpt_icon":0},{"id":"2558502333","title":"博安生物自主开发药物度拉糖肽注射液获批上市","url":"https://stock-news.laohu8.com/highlight/detail?id=2558502333","media":"金融界","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2558502333?lang=zh_cn&edition=full","pubTime":"2025-08-09 22:00","pubTimestamp":1754748019,"startTime":"0","endTime":"0","summary":"博安生物港交所公告，公司自主开发的博优平®已获得国家药品监督管理局的上市批准，用于成人2型糖尿病患者的血糖控制。博优平®是一种长效GLP-1受体激动剂，其在中国大陆的商业化由公司与上药控股合作开展。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/08/09220052328138.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BK1161","06955"],"gpt_icon":0},{"id":"2558042295","title":"博安生物港交所公告公司自主开发的博优平（度拉糖肽注射液）已获得国家药品监督管理局的上市批准用于成人2型糖尿病患者的血糖控","url":"https://stock-news.laohu8.com/highlight/detail?id=2558042295","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2558042295?lang=zh_cn&edition=full","pubTime":"2025-08-09 21:58","pubTimestamp":1754747924,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK1161","BK4144","GLP","06955","HEXmain","BK4590"],"gpt_icon":0},{"id":"2557544962","title":"博安生物：度拉糖肽注射液博优平在中国获批上市","url":"https://stock-news.laohu8.com/highlight/detail?id=2557544962","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557544962?lang=zh_cn&edition=full","pubTime":"2025-08-08 17:07","pubTimestamp":1754644043,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["BK1161","BLA.AU","06955"],"gpt_icon":0},{"id":"2557441575","title":"博安生物(06955.HK)：度拉糖肽注射液博优平®在中国获批上市","url":"https://stock-news.laohu8.com/highlight/detail?id=2557441575","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557441575?lang=zh_cn&edition=full","pubTime":"2025-08-08 17:04","pubTimestamp":1754643895,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BLA.AU","06955","BK1161"],"gpt_icon":0},{"id":"2557525304","title":"每日卖空追踪 | 博安生物 08月08日卖空量成交50.22万股，卖空比例为1.14%","url":"https://stock-news.laohu8.com/highlight/detail?id=2557525304","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557525304?lang=zh_cn&edition=full","pubTime":"2025-08-08 16:30","pubTimestamp":1754641835,"startTime":"0","endTime":"0","summary":"博安生物北京时间08月08日，涨7.73%，卖空量成交50.22万股%，较上一交易日减少75.17%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250808180324a6dacecf&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250808180324a6dacecf&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["06955","BK1161"],"gpt_icon":0},{"id":"2557546430","title":"港股异动 | 博安生物(06955)尾盘飙升逾16% 旗下度拉糖肽生物类似药BA5101获批上市","url":"https://stock-news.laohu8.com/highlight/detail?id=2557546430","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557546430?lang=zh_cn&edition=full","pubTime":"2025-08-08 15:46","pubTimestamp":1754639184,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，博安生物尾盘飙升逾16%，截至发稿，涨10.89%，报18.94港元，成交额6.45亿港元。消息面上，8月8日，国家药监局官网显示，博安生物申报的度拉糖肽注射液获批上市，用于成人2型糖尿病患者的血糖控制。值得注意的是，博安生物6月初宣布配售3840万股，净筹约3.96亿元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1327280.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":"港股异动 | 博安生物(06955)尾盘飙升逾16% 旗下度拉糖肽生物类似药BA5101获批上市","news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1161","06955"],"gpt_icon":0},{"id":"2557546839","title":"博安生物盘中异动 股价大涨5.09%","url":"https://stock-news.laohu8.com/highlight/detail?id=2557546839","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557546839?lang=zh_cn&edition=full","pubTime":"2025-08-08 15:30","pubTimestamp":1754638226,"startTime":"0","endTime":"0","summary":"2025年08月08日临近收盘15时30分，博安生物股票出现异动，股价快速上涨5.09%。截至发稿，该股报17.950港元/股，成交量1331.34万股，换手率2.32%，振幅9.07%。机构评级方面，在所有2家参与评级的机构中，100%的券商给予买入建议，无券商给予持有、卖出建议。博安生物股票所在的生物技术行业中，整体跌幅为2.06%。该公司在中国和海外市场开展业务。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250808153026a47cafe8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250808153026a47cafe8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["06955","BK1161"],"gpt_icon":0},{"id":"2557546856","title":"全球首款！博安生物“度拉糖肽生物类似药”获批上市","url":"https://stock-news.laohu8.com/highlight/detail?id=2557546856","media":"医药魔方Info","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557546856?lang=zh_cn&edition=full","pubTime":"2025-08-08 15:17","pubTimestamp":1754637466,"startTime":"0","endTime":"0","summary":"8月8日，国家药监局官网显示，绿叶制药旗下公司博安生物的度拉糖肽注射液获批上市，用于成人2型糖尿病患者的血糖控制。这是首款获批上市的国产度拉糖肽生物类似药。据礼来财报，2024年度拉糖肽全球销售额为52.535亿美元。根据博安生物介绍，BA5101的研发遵循中国、美国、欧盟等生物类似药相关研究指南。结果显示，BA5101能够快速、稳定地降低血糖和糖化血红蛋白，安全性耐受性良好，与度拉糖肽注射液原研产品的疗效和安全性一致。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250808152504a47cad34&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250808152504a47cad34&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["06955","BK1161"],"gpt_icon":0},{"id":"2557512181","title":"信达生物上半年产品收入超52亿元；礼来口服GLP-1药物减重效果低于预期","url":"https://stock-news.laohu8.com/highlight/detail?id=2557512181","media":"氨基观察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557512181?lang=zh_cn&edition=full","pubTime":"2025-08-08 11:47","pubTimestamp":1754624861,"startTime":"0","endTime":"0","summary":"信达生物业绩出色。8月7日，信达生物公告称，上半年总产品收入超52亿元，同比增超35%；第二季度产品收入超27亿元，同比增长超30%。礼来减重药物效果不及预期。8月7日，礼来的首个小分子口服GLP -1药物Orforglipron在72周试验中达成全部目标，实现平均减重11.2%。3）复宏汉霖HLX43治疗胸腺癌的I期临床试验获FDA许可8月7日，复宏汉霖宣布，PD-L ADC药物HLX43用于治疗胸腺癌的I期临床试验，获FDA批准。该结果公布后，公司美股盘一度前跌超12%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025080812554494d6fd8e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025080812554494d6fd8e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU1969619763.USD","BK1589","LLY","LU2328871848.SGD","LU2488822045.USD","09688","ZLAB","01801","BK1583","06955","BK1161","02696"],"gpt_icon":0},{"id":"2557552869","title":"每日卖空追踪 | 博安生物 08月07日卖空量成交148.6万股，卖空比例为10.95%","url":"https://stock-news.laohu8.com/highlight/detail?id=2557552869","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557552869?lang=zh_cn&edition=full","pubTime":"2025-08-07 16:30","pubTimestamp":1754555434,"startTime":"0","endTime":"0","summary":"博安生物北京时间08月07日，跌5.11%，卖空量成交148.6万股%，较上一交易日增加498.23%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250807174347a47aa84d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250807174347a47aa84d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","06955"],"gpt_icon":0},{"id":"2557584353","title":"港股异动 | 博安生物(06955)现跌超4% 公司拟折价配股净筹7.8亿港元 用于产品研发及商业化","url":"https://stock-news.laohu8.com/highlight/detail?id=2557584353","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557584353?lang=zh_cn&edition=full","pubTime":"2025-08-07 09:46","pubTimestamp":1754531216,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，博安生物现跌超4%，截至发稿，跌4.17%，报17.25港元，成交额7130.16万港元。消息面上，博安生物宣布，拟配售总计4800万股股份，占公告日期已发行股份总数约8.36%，配售价为每股16.42港元，较上一日收盘价折让约8.78%。值得注意的是，博安生物6月初宣布配售3840万股，净筹约3.96亿元。BA1302拟用于治疗多种实体瘤，此前已获得FDA授予的鳞状非小细胞肺癌和胰腺癌的孤儿药资格认定，正在中国进行1期临床研究。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1326642.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["06955","BK1161"],"gpt_icon":0},{"id":"2557842589","title":"8月7日早间博安生物在港交所公告于2025年8月6日公司及配售代理订立配售协议。可能根据配售事项出售的配售股份总数为48","url":"https://stock-news.laohu8.com/highlight/detail?id=2557842589","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557842589?lang=zh_cn&edition=full","pubTime":"2025-08-07 08:47","pubTimestamp":1754527627,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["HEXmain","BK1161","06955"],"gpt_icon":0},{"id":"2557586394","title":"博安生物(06955.HK)拟折让约8.78%配售4800万股 净筹约7.8亿港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2557586394","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557586394?lang=zh_cn&edition=full","pubTime":"2025-08-07 07:12","pubTimestamp":1754521974,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["06955","BK1161"],"gpt_icon":0},{"id":"2557855815","title":"博安生物拟折让8.78%配售4800万股 总筹7.88亿港元加码研发与商业化","url":"https://stock-news.laohu8.com/highlight/detail?id=2557855815","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557855815?lang=zh_cn&edition=full","pubTime":"2025-08-07 07:08","pubTimestamp":1754521680,"startTime":"0","endTime":"0","summary":"可能根据配售事项出售的配售股份总数为4800万股，相当于本公告日期的已发行股份总数约8.36%；及经配发及发行配售股份扩大的已发行股份总数约7.71%。假设总计4800万股配售股份将获出售，配售事项所得款项总额预期将为7.88亿港元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250807071002a6d759aa&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250807071002a6d759aa&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","06955"],"gpt_icon":0},{"id":"2557658371","title":"山东博安生物拟配售融资最高8300万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2557658371","media":"DoNews","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557658371?lang=zh_cn&edition=full","pubTime":"2025-08-06 18:23","pubTimestamp":1754475782,"startTime":"0","endTime":"0","summary":"2025年8月6日，山东博安生物技术公司计划通过配售方式融资最多8300万美元。此次融资将用于支持公司生物技术研发及市场拓展。山东博安生物技术总部位于中国山东省，是一家专注于生物制药领域的高科技企业。此次融资将通过增发新股或现有股东配售形式进行，具体方案及时间表尚未公布。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025080618235494d33236&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025080618235494d33236&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","06955"],"gpt_icon":0},{"id":"2557371665","title":"博安生物08月06日获主力加仓547.2万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2557371665","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557371665?lang=zh_cn&edition=full","pubTime":"2025-08-06 16:15","pubTimestamp":1754468143,"startTime":"0","endTime":"0","summary":"08月06日, 博安生物股价涨1.35%，报收18.00元，成交金额2.3亿元，换手率2.22%，振幅4.34%，量比0.67。博安生物今日主力资金净流入547.2万元，连续5日净流入，上一交易日主力净流入1131.1万元。该股近5个交易日下跌1.37%，主力资金累计净流入3455.2万元；近20日主力资金累计净流入1.6亿元，其中净流入天数为14日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250806170535a4785c43&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250806170535a4785c43&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","06955"],"gpt_icon":0},{"id":"2557983933","title":"每日卖空追踪 | 博安生物 08月05日卖空量成交8.86万股，卖空比例为0.48%","url":"https://stock-news.laohu8.com/highlight/detail?id=2557983933","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557983933?lang=zh_cn&edition=full","pubTime":"2025-08-05 16:30","pubTimestamp":1754382636,"startTime":"0","endTime":"0","summary":"博安生物北京时间08月05日，涨8.23%，卖空量成交8.86万股%，较上一交易日减少11.04%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250805172326a6d4346b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250805172326a6d4346b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","06955"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.boan-bio.com","stockEarnings":[{"period":"1week","weight":-0.0394},{"period":"1month","weight":-0.05},{"period":"3month","weight":0.8374},{"period":"6month","weight":0.9942},{"period":"1year","weight":0.934},{"period":"ytd","weight":0.8532}],"compareEarnings":[{"period":"1week","weight":0.0282},{"period":"1month","weight":0.0583},{"period":"3month","weight":0.0921},{"period":"6month","weight":0.1323},{"period":"1year","weight":0.4914},{"period":"ytd","weight":0.2769}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"山东博安生物技术股份有限公司是一家主要从事生物制药的中国公司。该公司主要从事治疗用抗体的开发、生产和商业化，专注于肿瘤学、代谢学、自身免疫学和眼科等治疗领域。该公司主要拥有三个技术平台：全人抗体转基因小鼠及噬菌体展示技术平台、双特异T-cell Engager技术平台、抗体药物偶联（ADC）技术平台。该公司主要在中国国内市场和海外市场开展其业务。","exchange":"SEHK","name":"博安生物","nameEN":"BOAN BIOTECH"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.34.7","shortVersion":"4.34.7","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"博安生物(06955)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供博安生物(06955)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"博安生物,06955,博安生物股票,博安生物股票老虎,博安生物股票老虎国际,博安生物行情,博安生物股票行情,博安生物股价,博安生物股市,博安生物股票价格,博安生物股票交易,博安生物股票购买,博安生物股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"博安生物(06955)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供博安生物(06955)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}